Skip to main content

Hologic Inc

HOLXDelisted
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
SEC CIK
0000859737

Hologic Inc was delisted in 2026; its insiders filed their last Form 4 on Apr 9, 2026; 706 institutions reported holding it in 13F filings for Q1 2026, worth $16.3B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Hologic Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Hologic Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Hologic Inc
NameTitleLast reported holdingLast filingFilings, past year
Macmillan Stephen PChairman, President and CEO0IndirectApr 9, 20264
Madaus Martin DDirector0IndirectApr 9, 20262
Oberton Karleen MarieChief Financial Officer0Apr 9, 20264
Dockendorff Charles JDirector0IndirectApr 9, 20262
Wendell Amy McBrideDirector0Apr 9, 20262
Stewart Stacey D.Director0Apr 9, 20262
Hantson LudwigDirector0Apr 9, 20262
Stamoulis ChristianaDirector0Apr 9, 20263
Cohn Benjamin JordanPrincipal Accounting Officer0Apr 9, 20264
McMillan Wayde D.Director0Apr 9, 20262
Verstreken JanGroup President, International0Apr 9, 20264
Mitchell Essex DChief Operating Officer0Apr 9, 20264
Schneiders Jennifer MPresident, Diag. Solutions0Apr 9, 20263
Mohtashami NanazDirector0Apr 9, 20262
Schnittker BrandonPresident, GYN Surgical0Apr 9, 20264
De Walt DianaSVP, Human Resources0Apr 9, 20262
Horvath Mark W.President, Breast & Skeletal0Apr 9, 20264
Liddy Anne M.General Counsel0Apr 9, 20264
Griffin John M.General Counsel182,514Nov 18, 20240
Anderson Erik SDiv. Pres., Breast & Skeletal23,231Nov 18, 20240
Garrett Scott TDirector48,611Mar 15, 20240
Crawford SallyDirector132,927Mar 11, 20240
Dunne Peter PaulSVP, Human Resources10,643Dec 15, 20230
Hellmann Elisabeth ASVP, Human Resources9,574Nov 16, 20230
Nawana NamalDirector18,221Mar 13, 20230
Thornal Kevin RGroup Pres, Global Diagnostics62,368Nov 17, 20220
Daugherty Sean S.Group President, BSH & Surg.49,091Feb 28, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 22, 2025 (view filing)Oct 202 daysStamoulis ChristianaDirectorSSale−7.40K$73.07−$540.9K−13.5%47.3K after10b5-1
Sep 23, 2025 (view filing)Sep 221 dayMacmillan Stephen PChairman, President and CEOSSale−138.4K$66.97−$9.27M−10.1%1.23M after3 lots10b5-1
May 9, 2025 (view filing)May 72 daysMadaus Martin DDirectorPPurchase+5.45K$55.24+$300.8KNew position5.45K after
Dec 6, 2024 (view filing)Dec 42 daysMitchell Essex DChief Operating OfficerSSale−24.9K$76.34−$1.90M−47.1%28.0K after
Sep 3, 2024 (view filing)Aug 295 daysOberton Karleen MarieChief Financial OfficerSSale−52.7K$80.56−$4.24M−38.5%84.0K after10b5-1
Aug 8, 2024 (view filing)Aug 62 daysSchnittker BrandonDiv. President, GYN SurgicalSSale−476$83.11−$39.6K−11.3%3.73K after
Aug 5, 2024 (view filing)Aug 14 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−5.09K$81.99−$417.6K−32.7%10.5K after
Aug 1, 2024 (view filing)Jul 302 daysMacmillan Stephen PChairman, President and CEOSSale−44.0K$81.70−$3.60M−3.7%1.16M after3 lots10b5-1
Jul 19, 2024 (view filing)Jul 172 daysMacmillan Stephen PChairman, President and CEOSSale−3.67K$80.13−$294.2K−0.3%1.16M after10b5-1
Jul 19, 2024 (view filing)Jul 172 daysStamoulis ChristianaDirectorSSale−9.04K$79.50−$718.6K−16.6%45.5K after10b5-1
Mar 15, 2024 (view filing)Mar 141 dayGarrett Scott TDirectorSSale−16.4K$75.50−$1.24M−25.3%48.6K after
Mar 11, 2024 (view filing)Mar 83 daysDockendorff Charles JDirectorSSale−1.47K$76.21−$111.6K−48.2%1.57K after10b5-1
Mar 11, 2024 (view filing)Mar 83 daysCrawford SallyDirectorSSale−9.04K$76.40−$690.6K−6.4%132.9K after
Jan 30, 2024 (view filing)Jan 291 dayOberton Karleen MarieChief Financial OfficerSSale−14.9K$75.00−$1.12M−12.6%103.9K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysDockendorff Charles JDirectorSSale−16.0K$72.00−$1.15M−91.6%1.47K after10b5-1
Dec 13, 2023 (view filing)Dec 112 daysGarrett Scott TDirectorSSale−10.0K$68.71−$687.1K−17.5%47.0K after
Dec 1, 2023 (view filing)Nov 292 daysMacmillan Stephen PChairman, President and CEOSSale−47.7K$70.41−$3.36M−3.7%1.24M after10b5-1
Nov 24, 2023 (view filing)Nov 213 daysMitchell Essex DDiv. President, GYN SurgicalSSale−7.50K$71.85−$538.9K−36.9%12.8K after
Jun 20, 2023 (view filing)Jun 155 daysGarrett Scott TDirectorSSale−10.0K$79.72−$797.2K−14.9%57.0K after
May 9, 2023 (view filing)May 54 daysMitchell Essex DDiv. President, GYN SurgicalSSale−2.39K$83.73−$200.1K−24.9%7.21K after
Feb 9, 2023 (view filing)Feb 72 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−9.13K$85.28−$778.4K−39.0%14.3K after
Dec 16, 2022 (view filing)Dec 142 daysHellmann Elisabeth ASVP, Human ResourcesSSale−1.65K$76.40−$126.0K−16.2%8.54K after
Dec 2, 2022 (view filing)Nov 302 daysMacmillan Stephen PChairman, President and CEOSSale−33.5K$75.65−$2.53M−1.4%2.31M after2 lots
Nov 17, 2022 (view filing)Nov 152 daysThornal Kevin RGroup Pres, Global DiagnosticsSSale−19.1K$75.32−$1.44M−23.5%62.4K after2 lots
Nov 16, 2022 (view filing)Nov 142 daysGriffin John M.General CounselSSale−26.9K$76.12−$2.05M−13.7%168.9K after2 lots
Nov 14, 2022 (view filing)Nov 113 daysMacmillan Stephen PChairman, President and CEOSSale−138.4K$75.71−$10.5M−5.4%2.44M after3 lots
Nov 3, 2022 (view filing)Nov 12 daysOberton Karleen MarieChief Financial OfficerSSale−14.5K$72.50−$1.05M−10.3%126.8K after
May 19, 2022 (view filing)May 172 daysVerstreken JanGroup President, InternationalSSale−6.50K$78.80−$512.2K−9.2%64.2K after
May 19, 2022 (view filing)May 172 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−3.84K$78.75−$302.7K−22.1%13.5K after
May 17, 2022 (view filing)May 134 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−7.05K$75.49−$532.4K−34.3%13.5K after2 lots
May 5, 2022 (view filing)May 32 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−2.18K$74.18−$161.6K−13.9%13.5K after
Feb 28, 2022 (view filing)Feb 244 daysDaugherty Sean S.Group President, BSH & Surg.SSale−2.18K$71.14−$155.0K−4.3%49.1K after
Nov 23, 2021 (view filing)Nov 194 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−2.57K$75.79−$194.8K−14.1%15.6K after
Aug 12, 2021 (view filing)Aug 102 daysCohn Benjamin JordanPrincipal Accounting OfficerSSale−5.00K$77.49−$387.4K−22.8%16.9K after
Aug 11, 2021 (view filing)Aug 92 daysGriffin John M.General CounselSSale−26.7K$75.62−$2.02M−17.8%123.6K after